Sandoz GmbH v. Roche Diagnostics GmbH
England and Wales High Court of Justice
[2004] EWHC 1313 (Ch), HC-2003-03648 (2004)
- Written by Margot Parmenter, JD
Facts
Roche Diagnostics GmbH (Roche) (defendant) was granted a UK patent for certain methods of preserving injectable liquids with active-protein ingredients, known in the industry as parenterals. The original patent was for three types of antimicrobial preservatives, used alone or combined in particular concentrations. Sandoz GmbH (plaintiff) sued to revoke the patent on the ground that it did not involve an inventive step. In response, Roche applied to amend the patent so that it involved only parenterals with erythropoietin (EPO) and applied a combination of at least two of the preservatives instead of any one of them alone. Sandoz argued that this amended patent described a method that was obvious at the time of filing, and that the patent was therefore invalid for failing to contain an inventive step. Roche maintained that the amended patent was nonobvious.
Rule of Law
Issue
Holding and Reasoning (Patten, J.)
What to do next…
Here's why 804,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.